Key result
Newer anti-cancer treatment agents have significantly increased cancer survivorship, highlighting the need to balance oncological efficacy with cardiovascular care.
Highlights the evolving landscape of cardio-oncology and the need to balance cancer treatment efficacy with cardiovascular safety.
May prompt integrated cardio-oncology monitoring in survivors; leaves open optimal risk-stratification strategies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Angel López‐Candales (2019) studied this question. Newer anti-cancer treatment agents have significantly increased cancer survivorship, highlighting the need to balance oncological efficacy with cardiovascular care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: